SciSparc Ltd. (NASDAQ:SPRC) shares climbed 38.87% to $0.38 in after-hours trading on Wednesday.

In the regular session, the Israeli clinical-stage specialty pharmaceutical company closed at $0.27, down 18.08%, according to Benzinga Pro data.

SciSparc experienced an elevated trading session on Wednesday. The volume rose to 16.82 million, 5.9 times its average trading volume of 2.86 million.

Agentic AI Pivot in Focus

The stock move followed a Monday announcement that the company appointed Prof. Jacob Nagel to its Scientific Advisory Board for AI and Cybersecurity.

According to the company, Nagel is a visiting professor at the Technion-Israel Institute of Technology. He served as head of Israel’s National Security Council and acting national security adviser from 2016 to 2017.

SciSparc said the appointment supports its planned entry into agentic AI, meaning systems that autonomously plan and execute tasks. The company said it is still evaluating technologies, partnerships and opportunities in the sector.

The appointment follows the recent addition of Technion AI professor Carmel Domshlak to the board.

Trading Metrics, Technical Analysis

SciSparc has a market capitalization of about $555,280. Over the past 52 weeks, its stock has traded as high as $29.88 and as low as $0.23.

SPRC has a Relative Strength Index (RSI) of 14.62.

Over the past 12 months, the small-cap biotech stock has fallen 98.78%.

Benzinga’s Edge Stock Rankings indicate SciSparc stock has a negative price trend across all time frames.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo Courtesy: Andrey_Popov on Shutterstock.com